TradeGel
Antibacterial Skin Protection Solution
Health Tech & Life Sciences
Non Active, Feb 2022 ceased to operate
Company Overview
Snapshot
Founded in January 2014 by D. Glikman, TradeGel operates with 1–10 employees. The company holds a patent for its technology. TradeGel ceased operations in February 2022.
Business overview
TradeGel develops advanced antibacterial and antiseptic solutions for skin protection within the Health Tech & Life Sciences sector. Its core product, Hetromistin Instant Crystal HetroCleaner, is an antiseptic, antibacterial, and hypoallergenic solution designed for daily skin care. The company serves consumers and healthcare industries with products aimed at reducing the risk of fungal infections and providing general skin hygiene, operating within the pharmaceuticals, therapeutics, and dermatology categories.
Log in to access full profile ›Company Intelligence Q&A
- What is TradeGel's primary product?
- TradeGel's primary product is Hetromistin Instant Crystal HetroCleaner, an antiseptic, antibacterial, and hypoallergenic solution for skin protection.
- When was TradeGel founded?
- TradeGel was founded in January 2014.
- What is the status of TradeGel's operations?
- TradeGel ceased to operate in February 2022.
- Does TradeGel hold any patents?
- Yes, TradeGel holds a patent for its technology.
- Who is the founder of TradeGel?
- D. Glikman is the founder and Sales Executive of TradeGel.